Circulating Biomarker Panels in Alzheimer's Disease.

  title={Circulating Biomarker Panels in Alzheimer's Disease.},
  author={Sachli Zafari and Christina Backes and Eckart Meese and Andreas Keller},
  volume={61 6},
The early diagnosis of diseases frequently represents an important unmet clinical need supporting in-time treatment of pathologies. This also applies to neurodegenerative diseases such as Alzheimer's disease (AD), the most common form of dementia, estimated to affect millions of individuals worldwide. The respective diagnostic and prognostic markers, especially for the preclinical stages of AD, are expected to improve patients' outcome significantly. In the last decades, many approaches to… CONTINUE READING